Here the authors report that global or adipocyte-specific deletion of REDD1 inhibits diet induced obesity, insulin resistance, liver steatosis and inflammation in mice, at least in part via reduced atypical NF-κB activation. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.